Company Continues to Leverage IP Portfolio LOS ANGELES—(BUSINESS WIRE)—Advanced Cell Technology, Inc.(OTCBB: ACTC – News) announced today that it has entered into an…
Data and Safety Monitoring Board (DSMB) Grants Approval to Proceed with Treatment of Second Patient Cohort MARLBOROUGH, Mass. — July…
MARLBOROUGH, Mass. – July 2, 2012 – Advanced Cell Technology, Inc. (“ACT”; OTCBB: ACTC), a leader in the field of regenerative…
Advanced Cell Technology’s Chief Scientific Officer, Dr. Robert Lanza will be featured on a Barbara Walters Special called “Live to…
Advanced Cell Technology’s (ACT) Ethics Advisory Board (EAB) provided oversight and counsel for the research that culminated in publication of…
In the U.S., the number of payday loans and personal loans issued to the population has increased. The most common…
American scientists have developed a new method for obtaining embryonic stem cells, which allows the life of the embryo to…
Regenerative medicine is not just a new technology, but a fundamentally different direction of medicine. This is a direction that…
WORCESTER, Mass.—(BUSINESS WIRE)—Advanced Cell Technology, Inc. (OTCBB: ACTC.PK – News), announced today that their study investigating the feasibility of producing functional, oxygen-carrying red…
MARLBOROUGH, Mass.– Advanced Cell Technology, Inc. (“ACT”; OTCBB:ACTCD), a leader in the field of regenerative medicine, announced today that the US…